MedPath

LORAZEPAM

Lorazepam Tablet

Approved
Approval ID

84e74f60-4e4f-412f-a3ff-f3252838f371

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 17, 2010

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LORAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-143
Application NumberANDA072926
Product Classification
M
Marketing Category
C73584
G
Generic Name
LORAZEPAM
Product Specifications
Route of AdministrationORAL
Effective DateMay 21, 2010
FDA Product Classification

INGREDIENTS (5)

LORAZEPAMActive
Quantity: 0.5 mg in 1 1
Code: O26FZP769L
Classification: ACTIB
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT

LORAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-584
Application NumberANDA072927
Product Classification
M
Marketing Category
C73584
G
Generic Name
LORAZEPAM
Product Specifications
Route of AdministrationORAL
Effective DateMay 21, 2010
FDA Product Classification

INGREDIENTS (5)

LORAZEPAMActive
Quantity: 1 mg in 1 1
Code: O26FZP769L
Classification: ACTIB
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LORAZEPAM - FDA Drug Approval Details